Bioburden Testing Market is Expected to Reach $565.6 Million by 2019

Date: 2015-08-31

“The bioburden testing market is expected to reach $565.6 million by 2019 from $354.4 million in 2014, at a CAGR of 9.8% from 2014 to 2019. This market is segmented on the basis of products, test types, applications, end users, and regions. On the basis of end users, the market is segmented into pharmaceutical and biotechnology companies, medical device manufacturers, contract manufacturing organizations (CMOs), manufacturers of food & beverage and agricultural products, and microbial testing laboratories. The CMOs segment is expected to grow at the highest CAGR in the coming five years. Growth in this segment will be driven by the rising demand for cost-effective alternatives for manufacturing in emerging as well as developed countries.

The major factors contributing to the growth of the global bioburden testing market include the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the microbial identification market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination. However, high cost of instruments and complex and time-consuming regulatory standards to lengthen the approval process in some countries may hinder the growth of this market.

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample